These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11862962)

  • 1. From the Centers for Disease Control and Prevention. Fibrosing skin condition among patients with renal disease--United States and Europe, 1997-2002.
    JAMA; 2002 Feb; 287(7):838. PubMed ID: 11862962
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrosing skin condition among patients with renal disease--United States and Europe, 1997-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jan; 51(2):25-6. PubMed ID: 11820525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis--setting the record straight.
    Cowper SE; Bucala R; Leboit PE
    Semin Arthritis Rheum; 2006 Feb; 35(4):208-10. PubMed ID: 16461067
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrogenic fibrosing dermopathy with recurrence after allograft failure.
    Goddard DS; Magee CC; Lazar AJ; Miller DM
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S109-11. PubMed ID: 17434031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nephrogenic fibrosing dermopathy].
    Shelekhova KV; Kazakov DV; Michal M
    Arkh Patol; 2006; 68(1):42-3. PubMed ID: 16544538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic fibrosing dermopathy: are ACE inhibitors the missing link?
    Fazeli A; Lio PA; Liu V
    Arch Dermatol; 2004 Nov; 140(11):1401. PubMed ID: 15545556
    [No Abstract]   [Full Text] [Related]  

  • 7. The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature.
    Wahba IM; White K; Meyer M; Simpson EL
    Nephrol Dial Transplant; 2007 Feb; 22(2):631-6. PubMed ID: 17124282
    [No Abstract]   [Full Text] [Related]  

  • 8. Dermatological aspects of medicine: recent advances in nephrology.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Jan; 30(1):98-102. PubMed ID: 15663523
    [No Abstract]   [Full Text] [Related]  

  • 9. Can scleromyxedema be differentiated from nephrogenic fibrosing dermatopathy by the distribution of the infiltrate?
    Satter EK; Metcalf JS; Maize JC
    J Cutan Pathol; 2006 Nov; 33(11):756-9. PubMed ID: 17083697
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephrogenic systemic fibrosis].
    Pintér I; Vágási K; Wittmann I; Nagy J
    Orv Hetil; 2007 Sep; 148(38):1801-4. PubMed ID: 17872335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear.
    Cowper SE; Bucala R
    Am J Dermatopathol; 2003 Aug; 25(4):358. PubMed ID: 12876500
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy.
    Schmook T; Budde K; Ulrich C; Neumayer HH; Fritsche L; Stockfleth E
    Nephrol Dial Transplant; 2005 Jan; 20(1):220-2. PubMed ID: 15632355
    [No Abstract]   [Full Text] [Related]  

  • 13. What nephrogenic fibrosing dermopathy might be.
    LeBoit PE
    Arch Dermatol; 2003 Jul; 139(7):928-30. PubMed ID: 12873893
    [No Abstract]   [Full Text] [Related]  

  • 14. Epoetin and nephrogenic systemic fibrosis.
    Saab G
    J Am Acad Dermatol; 2008 Jan; 58(1):174-5. PubMed ID: 18158932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiovascular disease in kidney transplantation].
    Marcén R; Pascual J
    Nefrologia; 2001; 21(2):104-14. PubMed ID: 11464644
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature.
    Cuffy MC; Singh M; Formica R; Simmons E; Abu Alfa AK; Carlson K; Girardi M; Cowper SE; Kulkarni S
    Nephrol Dial Transplant; 2011 Mar; 26(3):1099-101. PubMed ID: 21079195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
    Cowper SE; Kuo PH; Bucala R
    Arthritis Rheum; 2007 Oct; 56(10):3173-5. PubMed ID: 17907160
    [No Abstract]   [Full Text] [Related]  

  • 18. The pitfalls of a purely clinical definition of nephrogenic systemic fibrosis: comment on the article by Todd et al.
    Introcaso CE; Brunelli SM; Gelfand JM; Malik AS; Murashima M; Ahmed I; Feldman HI; Margolis DJ
    Arthritis Rheum; 2008 May; 58(5):1552; author reply 1552-4. PubMed ID: 18438819
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
    Galan A; Cowper SE; Bucala R
    Curr Opin Rheumatol; 2006 Nov; 18(6):614-7. PubMed ID: 17053507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrogenic fibrosing dermopathy].
    Engelen JW; Kooistra MP; Canninga-van Dijk MR; Toonstra J; Sigurdsson V
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2435-8. PubMed ID: 14694555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.